South and Central America Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Method, and CTC Analysis), Application (Clinical/Li

South and Central America Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Method, and CTC Analysis), Application (Clinical/Liquid Biopsy, and Research), and End-User (Hospitals and Clinics, Research and Academic Institutes, and Diagnostic Centers)

The South & Central America circulating tumor cell (CTC) diagnostics market is expected to reach US$ 214.0 million by 2028 from US$ 116.9 million in 2021. The market is estimated to grow at a CAGR of 9.0% from 2021 to 2028.

Health systems across the region are witnessing a substantial increase in the prevalence of cancer. Thus, the increased prevalence of cancer across South & Central America is propelling the demand for circulating tumor cell diagnostics. The analysis and detection of circulating tumor cells assist in early patient diagnosis, and the prognosis helps determine accurate treatment for these patient. The CTC diagnostics products to detect various types of cancers, including prostate cancer, breast cancer, colorectal cancer, kidney cancer, lymphomas, lung cancer, and melanoma. There has been a high demand for CTC diagnostics in recent years due the reliability and accuracy of this technique in identifying the risk of various cancers and monitoring different cancer treatments.

Brazil, Argentina, Uruguay, Chile, Peru, and Colombia were hit by the second wave of corona infection. Brazil has registered the majority of deaths due to this disease in South and Central America. Moreover, COVID-19 impacted the number of patients undergoing cancer diagnosis, screening, and treatment. The havoc created by COVID-19 compelled majority of pharmaceutical and biotechnology companies to shift their focus on the development of novel therapies and diagnostics for this disease. Moreover, continuous strain due to the COVID-19 outbreak impacted supply chains, company operations, and distribution systems, including their R&D abilities, and novel product launches and services. Thus, the COVID-19 pandemic hampered the circulating tumor cell (CTC) diagnostics market in SCAM during the forecast period.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the circulating tumor cell (CTC) diagnostics market. The South & Central America circulating tumor cell (CTC) diagnostics market is expected to grow at a good CAGR during the forecast period.

South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Segmentation

By Technology

CTC detection and Enrichment Method CTC Direct Detection Methods CTC Analysis By Application

Clinical/Liquid Biopsy Risk Assessment Screening and Monitoring Research Cancer Stem Cell and Tumorigenesis Research Drug/Therapy Development By End-User

Hospitals and Clinics Research and Academic Institutes Diagnostic Centers By Country

Brazil Argentina Rest of South & Central America Companies Mentioned

Thermo Fisher Scientific Inc. Stemcell Technologies Inc. Qiagen Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation) Fluxion Biosciences

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America circulating tumor cell (CTC) diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America circulating tumor cell (CTC) diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.